India 
USA
UK
South Africa
Australia
Philippines
Germany
Netherlands
Mexico
Brazil
Canada
Lupin is committed to delivering high-quality medicines to patients and customers across the globe. This commitment shines through in our focus on quality.
Our quality and compliance teams are led by seasoned professionals with years of experience in global quality operations and compliance in relevant pharmaceutical segments. Dedicated technical training teams help enhance the capabilities of our quality and compliance teams by conducting training sessions for them across our sites.
This improvement endeavour is further complemented by Lupin’s Corporate Quality Assurance (CQA) cell’s continuous evaluations, which ensure strong linkage and knowledge transfer between our quality, manufacturing and research teams. Over 700 CQA professionals work across our manufacturing locations to develop and implement procedures aiming for the gold standard in quality and compliance.
Lupin’s quality governance model is shaped by consistent benchmarking of processes globally, through collaboration with regulatory bodies, industry working groups and subject matter experts. We leverage the industry’s best minds to upgrade our CQA teams’ technical expertise, continually.
Our Global Quality Action Plan (GQAP) is the roadmap that drives quality standardisation across Lupin’s manufacturing entities. Over time, we have introduced various technologies and automated operations at our facilities. These include the use of next-gen robotics in our laboratories, best-in-class Electronic Batch Processing Systems, Laboratory Information Management Systems (LIMS), Electronic Document Management System (eDMS), and quality assurance management systems.
Our automated systems are complemented by skilled personnel who regularly share feedback to facilitate continuous improvements in our processes.
Our Quality Policy puts quality and safety before profit and is incumbent upon our employees, suppliers, and contractors. We establish and maintain high standards of quality for products manufactured in-house and at contract manufacturing sites. Our products are manufactured and marketed in compliance with all quality parameters relating to identity, purity, safety and efficacy, including cGMP and cGLP norms. We follow well-defined quality assurance and validated systems.
Lupin is committed to a transparent and collaborative partnership with regulatory agencies. We provide routine updates to regulatory agencies on our compliance commitment. Our CQA conducts periodic quality audits, and reviews compliance with regulatory inspections.
Our dedicated investigative teams consistently scrutinise quality standards and ensure adherence to rigorous SOPs. We are consistently searching for ways to strengthen our stringent quality standards.
